LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Tim Lemmen New Division Leader at Orchid
People In The News

Tim Lemmen New Division Leader at Orchid

November 12, 2013 1 min read Premium comments

Advertisement

Tim Lemmen New Division Leader at Orchid
Tim Lemmen, Ph.D.

Orchid Orthopedic Solutions has announced that it is welcoming a new division Lean leader, Tim Lemmen, Ph.D. Orchid indicates that it has added Tim Lemmen to help drive its Lean methodology throughout the organization.

Dr. Lemmen has a wide variety of experience at GE, NCR, Morton Thiokol and Electrolux in technical, operational and customer facing roles. Most recently, he was the VP of Quality and Continuous Improvement for the North American division of Electrolux, where he introduced Lean Manufacturing to the manufacturing of the Frigidaire product line. In prior roles, Dr. Lemmen worked extensively with Six Sigma resulting in his certification as a Master Black Belt with GE Power Systems. He led and developed many polymer development projects while with GE Plastics, and led all technical services for GE Specialty Chemicals Europe as an ex pat. Dr. Lemmen earned a PhD in Inorganic Chemistry from Indiana University and a BS in Chemistry from the University of Wisconsin at Madison.

Dr. Lemmen told OTW, “My initial focus is to increase our operational stability and capability using Lean Manufacturing and Six Sigma to be able to take better care of our customers as we drive dramatic growth into the company.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy